FDA
-
-
-
-
-
-
-
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
-
-
-
-
-
-
-
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
-
-
-
-
-
-
-
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
-
-
-
-
-
-
-
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
-
-
-
-
-
-
-
180 Life Sciences Announces Presentation at the Gordon Conference
-
-
-
-
-
-
-
180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial
-
-
-
-
-
-
-
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

